Human Insulin Industry, March 2015 Market Reports from Top Publishers

You might be interested in: insulin, biosimilar, therapeutics.


 
1-10 of 18 reports for Human Insulin

Adocia (ADOC) - Financial and Strategic SWOT Analysis Review

Adocia (ADOC) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Adocia is a biotechnology company. The company offers insulin therapy and the treatment of the diabetic foot ulcer. Its products include PDGF-BB, BioChaperone Insulins combo based on Glargine, ...

2015 Deep Research Report on Global Recombinant Human Insulin Industry

2015 Deep Research Report on Global Recombinant Human Insulin Industry

  • $ 2 600
  • Industry report
  • January 2015
  • by QY Research Group

Summary 2015 Deep Research Report on Global Recombinant Human Insulin Industry is a professional and depth research report on Global Recombinant Human Insulin industry. For overview analysis, the report ...

Tonghua Dongbao Pharmaceutical Co., Ltd. (Symbol:600867) SWOT Analysis, Strategy, Revenues and Profits

Tonghua Dongbao Pharmaceutical Co., Ltd. (Symbol:600867) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Adocia (ADOC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Adocia (ADOC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Adocia is a biotechnology company. The company offers insulin therapy and the treatment of the diabetic foot ulcer. Its products include PDGF-BB, BioChaperone Insulins combo based on Glargine, ...

Biomm S.A. (BIOM4) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Biomm S.A. (BIOM4) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Biomm S.A. (Biomm) is a biotechnology company. The company develops technology for the production of human insulin and other recombinant proteins. Its technology is used in the production of therapeutic ...

2014 Market Research Report on Global Insulin Industry

2014 Market Research Report on Global Insulin Industry

  • $ 2 200
  • Industry report
  • November 2014
  • by QY Research Group

Summary 2014 Market Research Report on Global Insulin Industry is a professional and depth research report on Global Insulin industry. For overview analysis, the report introduces Insulin basic information ...

Insulin Markets in China

Insulin Markets in China

  • $ 4 000
  • Industry report
  • September 2014
  • by Asia Market Information & Development Company

China's demand for Insulin has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has ...

Asia Pacific Insulin Market Review to 2018 - Transition from Human Insulin to Analog Insulin

Asia Pacific Insulin Market Review to 2018 - Transition from Human Insulin to Analog Insulin

  • $ 1 500
  • Industry report
  • September 2014
  • by Ken Research Private

EXECUTIVE SUMMARY The industry research publication titled ‘Asia Insulin Market Review to 2018 - Transition from Human Insulin to Analog Insulin' presents a comprehensive analysis of market size by value ...

India Insulin Market Review to 2018 - Intensifying Strategic Alliances Between Companies

India Insulin Market Review to 2018 - Intensifying Strategic Alliances Between Companies

  • $ 900
  • Industry report
  • September 2014
  • by Ken Research Private

EXECUTIVE SUMMARY The industry research publication titled ‘India Insulin Market Review to 2018 - Intensifying Strategic Alliances Between Companies' presents a comprehensive analysis of market size ...

China Insulin Market Review to 2018 - Increasing Focus on R&D Investments

China Insulin Market Review to 2018 - Increasing Focus on R&D Investments

  • $ 900
  • Industry report
  • September 2014
  • by Ken Research Private

EXECUTIVE SUMMARY The industry research publication titled ‘China Insulin Market Review to 2018 - Increasing Focus on R&D Investments' presents a comprehensive analysis of market size by volume and ...

About 300 reports for Human Insulin

Download Unlimited Documents from Trusted Public Sources


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.